SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

SNDX is currently covered by 4 analysts with an average potential upside of $8.89 (47.1%) from yesterday's end of day stock price of $16.57. Syndax Pharmaceuticals activity chart has currently 37 price targets and 56 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.24% with an average time for these price targets to be met of 310.36 days.

Highest price target for SNDX is $26, Lowest price target is $12, average price target is $19.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 17-Oct-2023. First documented stock forecast 31-Mar-2016.

Currently, out of the existing stock ratings of SNDX - 16 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

33

1 months 17 days ago

0/3 (0%)

$14.06 (64.02%)

Buy

42

$30.49 (264.90%)

38

2 months 2 days ago

3/10 (30%)

$12.85 (77.18%)

749

Buy

34

$17.43 (105.19%)

31

4 months 8 days ago

1/4 (25%)

$7.93 (38.29%)

182

Buy

35

$18.43 (111.23%)

31

4 months 8 days ago

3/6 (50%)

$9.68 (50.20%)

355

Buy

37

$20.43 (123.30%)

34

6 months 25 days ago

2/8 (25%)

$12.35 (60.24%)

896

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 310.36 days on average for the stock forecasts to be realized with a an average price target met ratio 34.24

Which analyst has the current highest performing score on SNDX (Syndax Pharmaceuticals) with a proven track record?

EDWARD WHITE

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

Edward White works at HC WAINWRIGHT and has 3 price targets and 3 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Edward White with highest potential upside - $30.49

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

David Lebowitz with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart